**Acknowledgements**

HGF=hematopoietic growth factors

IDL=intermediate density lipoprotein

IRPs=iron regulatory proteins

LDL=low-density lipoprotein

MAO=monoamine oxidase

MDA=malondialdehyde

MW=molecular weight

ND=not determined

NAD(P)+

MAPK=mitogen-activated protein kinase

NQO1=NAD(P)H:quinoneoxidoreductase 1

NTBI=non-transferrin bound iron

ODC=ornithine decarboxylase 6-OHDA=6-hydroxydopamine

RNS=reactive nitrogen species ROS=reactive oxygen species SAM=*S*-adenosyl methionine

PD=Parkinson's disease PPO=polyphenol oxidase

RBC=red blood cell

MPTP=1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

=nicotinamide adenine dinucleotide phosphate NAD(P)H=reduced nicotinamide adenine dinucleotide phosphate

=inhibition constant LD50=lethal dose at 50%

LIP=labile iron pool LPI=labile plasma iron

IL-3=interleukin-3

*Ki*

HMG-Co A=3-hydroxy-3-methylglutaryl-coenzyme A

380 Pharmacology and Nutritional Intervention in the Treatment of Disease

hTERT=human telomerase reverse transcriptase HTLV-I=human T-cell lymphotropic virus type I

> This work was partially supported by the Office of Higher Education Commission and Mahidol University under the National Research University Initiative, Thailand Research Fund through Professor Suthat Fucharoen, MD. and by a Research Chair Grant from the National Science and Technology Development Agency (NSTDA) and Mahidol University through Professor Suthat Fucharoen, MD.
